Pharmaron Beijing Co., Ltd. Class H (3759) Stock Statistics & Valuation Metrics

Pharmaron Beijing Co., Ltd. Class H has a market cap or net worth of HK$73.68B. The enterprise value is HK$39.54K.

Pharmaron Beijing Co., Ltd. Class H has 359,977,870 shares outstanding. The number of shares has decreased by -2.65% in one year.

Pharmaron Beijing Co., Ltd. Class H’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 7.84%.

The current PE Ratio of Pharmaron Beijing Co., Ltd. Class H is 40.2. Pharmaron Beijing Co., Ltd. Class H’s PEG ratio is -2.70.

In the last 12 months, Pharmaron Beijing Co., Ltd. Class H had revenue of 14.10B and earned 1.66B in profits. Earnings per share was 0.94.

In the last 12 months, operating cash flow was 3.01B and capital expenditures -2.70B, giving a free cash flow of 304.88M billion.

Pharmaron Beijing Co., Ltd. Class H pays an annual dividend of HK$0.23, resulting in a dividend yield of 1.04%

Pharmaron Beijing Co., Ltd. Class H upcoming earnings date is Aug 31, 2026, TBA (Not Confirmed).

Pharmaron Beijing Co., Ltd. Class H as a current ratio of 0.93, with Debt / Equity ratio of 43.14%

In the past 12 months, Pharmaron Beijing Co., Ltd. Class H has paid 357.52M in taxes.

Pharmaron Beijing Co., Ltd. Class H EV to EBITDA ratio is 10.16, with an EV/FCF ratio of 60.52.

Pharmaron Beijing Co., Ltd. Class H has HK$2.97B in cash and marketable securities with HK$7.08B in debt, giving a net cash position of -HK$4.11B billion.

Gross margin is 34.12%, with operating margin of 13.68%, and net profit margin of 11.80%.

The average price target for Pharmaron Beijing Co., Ltd. Class H is HK$29.28, which is 11.43% higher than the current price. The consensus rating is Strong Buy